immunolog
john
elli
dvm
phd
bovin
respiratori
diseas
complex
brdc
continu
major
caus
morbid
mortal
econom
loss
cattl
product
system
despit
widespread
use
antibiot
vaccin
notwithstand
likelihood
mani
manag
practic
current
use
cattl
product
vaccin
arriv
feedlot
provid
necessari
optim
condit
develop
protect
immun
better
understand
role
immun
respons
pathogenesi
prophylaxi
brdc
like
aid
better
control
syndrom
moreov
increas
concern
use
antibiot
livestock
percept
possibl
neg
implic
anim
agriculturerel
antimicrobi
resist
human
medicin
indic
manipul
bovin
immun
system
may
becom
increasingli
import
diseas
manag
futur
therefor
concern
dictat
better
understand
rumin
immun
system
health
diseas
like
becom
prioriti
focu
continu
research
articl
concern
role
immun
system
pathogen
diseasespar
role
brdc
focus
recent
advanc
knowledg
sinc
previou
issu
veterinari
clinic
north
america
food
anim
practic
dealt
respiratori
diseas
cattl
respiratori
tract
mucos
surfac
differ
bodi
surfac
infecti
agent
interact
host
diseas
may
occur
requir
unimped
access
air
alveoli
result
close
contact
extern
intern
environ
requir
gaseou
exchang
occur
mucos
surfac
evolv
filter
system
capabl
remov
particl
small
jlm
reach
alveoli
gross
structur
basi
filter
system
confirm
turbin
trachea
bronchi
turbul
creat
movement
air
within
structur
microscop
featur
filter
system
compris
cilia
move
particul
debri
toward
extern
nare
mucos
line
respiratori
tract
coat
mucou
contain
antimicrobi
solubl
factor
lysozym
immunoglobulin
perform
trap
antisept
function
role
viral
agent
alter
destroy
structur
integr
filter
system
cilia
line
epitheli
cell
well
establish
import
nonspecif
phagocyt
digest
function
resid
infiltr
bronchoalveolar
macrophag
bam
neutrophil
effect
variou
virus
bacteri
virul
factor
function
well
recogn
recent
studi
better
address
variou
host
pathogen
factor
interact
molecular
level
alter
efficaci
scaveng
featur
phagocyt
role
bacteri
virul
factor
ruminantspecif
leukotoxin
lkt
produc
mannheimia
pasteurella
haemolytica
recogn
sinc
recent
studi
begun
better
elucid
molecular
basi
interact
lkt
bovin
immun
system
demonstr
toxin
bind
specif
group
adhes
molecul
known
integrin
notabl
specif
bind
lkt
cellular
receptor
result
regul
variou
metabol
pathway
associ
increas
intracellular
calcium
tyrosin
kinas
activ
addit
destruct
target
cell
specif
bind
lkt
recent
shown
regul
transcript
translat
sever
cytokin
includ
interleukin
il
l
tumor
necrosi
factora
mediat
proinflammatori
function
tissu
pretreat
isol
bam
interferona
shown
enhanc
product
secret
inflammatori
medic
practic
implic
latter
invitro
result
may
explain
pathogen
synerg
bovin
herpesvirusl
bacteria
brdc
viral
induct
interferon
may
actual
enhanc
patholog
inflammatori
process
lung
member
famili
low
molecular
weight
cytokin
known
collect
chemokin
recent
studi
cattl
document
bovin
function
primari
chemoattract
neutrophil
inflammatori
site
includ
lung
haemolytica
appar
upregul
product
cytokin
therebi
increas
migrat
neutrophil
infect
tissu
contrast
calv
experiment
bovin
respiratori
syncyti
viru
brsv
infect
neutrophil
infiltr
airway
parenchyma
promin
haemolyticaassoci
pneumonia
express
reduc
studi
calv
bovin
leukocyt
adhes
defici
congenit
lack
express
demonstr
adhes
molecul
essenti
initi
passag
neutrophil
extens
extracellular
matrix
pulmonari
airway
addit
express
adhes
molecul
intracellular
adhes
moleculeion
bronchiolar
alveolar
epithelium
arteri
venou
endothelium
bam
neutrophil
upregul
calv
experiment
infect
haemolytica
compar
salineinocul
control
result
compat
hypothesi
molecul
also
play
import
role
leukocyt
infiltr
therebi
import
pathogenesi
inflamm
tissu
damag
lung
relatedli
recent
investig
document
addit
control
growth
haemolytica
tilmicosin
commonli
use
antibiot
may
reduc
pulmonari
inflamm
induc
apoptosi
program
cell
death
neutrophil
reduc
leukotrien
secretioni
apoptot
neutrophil
lyse
releas
tissuedamag
proteolyt
enzym
amplif
inflammatori
injuri
haemolyticainfect
lung
prevent
chang
occur
without
effect
neutrophil
infiltr
function
identif
specif
host
molecul
involv
pathogen
inflamm
rais
possibl
specif
blockad
express
block
activ
ligand
antibodi
bind
may
use
approach
reduc
diseas
infect
anim
howev
remain
seen
whether
reductionist
approach
target
one
compon
obvious
complex
interact
compris
solubl
mediat
overlap
activ
produc
practic
prevent
therapeut
result
despit
recent
result
demonstr
posit
effect
oral
administ
human
recombin
interferon
alpha
weight
gain
feedlot
cattl
almost
complet
failur
applic
recombin
bovin
cytokin
therapeut
prevent
agent
cattl
attest
difficulti
reductionist
approach
anoth
relat
complic
factor
applic
molecularli
target
therapi
cattl
difficulti
accur
assess
stage
diseas
individu
anim
continu
work
aim
possibl
practic
measur
acutephas
protein
may
provid
better
mean
identifi
candid
therapi
acutephas
protein
serum
amyloid
haptoglobin
alpha
iacid
glycoprotein
produc
liver
respons
proinflammatori
cytokin
ili
tumor
necrosi
factora
recent
serum
concentr
serum
amyloid
haptoglobin
use
discrimin
acut
chronic
inflammatori
condit
cattl
practic
applic
test
method
almost
certainli
depend
develop
cowsid
test
intervent
decis
made
time
cattl
process
role
nonspecif
immunosuppress
mediat
bovin
herpesvirusi
bovin
viral
diarrhea
viru
lesser
extent
viru
respiratori
diseas
cattl
part
current
dogma
veterinari
medicin
support
invivo
invitro
data
review
previou
issu
veterinari
clinic
north
america
food
anim
practic
recent
studi
ad
littl
knowledg
area
except
suggest
brsv
may
also
bovin
viral
diarrhea
viru
brsv
may
synergist
neg
affect
local
system
immun
function
u
current
mechan
brsvmediat
immunosuppress
poodi
understood
avail
data
indic
appar
role
prostaglandin
secret
inhibit
ili
secret
specif
immun
respons
pathogen
gener
thought
confer
protect
immun
howev
recent
data
highlight
diseasecaus
potenti
pathogenspecif
immun
respons
role
specif
immun
respons
enhanc
bovin
respiratori
syncyti
viru
brsv
associ
respiratori
diseas
remain
controversi
despit
volumin
epidemiolog
data
indic
rsvassoci
diseas
becom
less
sever
age
herd
immun
increas
cattl
human
conflict
result
report
recent
studi
use
formalininactiv
alumadjuv
brsv
vaccin
formul
similarli
inactiv
human
respiratori
syncyti
viru
hrsv
vaccin
reportedli
associ
enhanc
respiratori
diseas
human
pediatr
patient
hrsv
infect
experiment
inactiv
brsv
vaccin
test
stimul
product
high
concentr
nonneutr
antibodi
vaccin
calv
howev
one
studi
report
significantli
sever
pulmonari
anoth
report
spare
brsvassoci
lung
lesion
subsequ
challeng
virul
viru
dose
brsv
respect
vaccin
inactiv
vaccin
may
part
account
dispar
result
rel
lowdos
brsv
antigen
content
vaccin
may
associ
diseas
enhanc
wherea
highdos
vaccin
appar
stimul
diseasespar
immun
respons
howev
possibl
remain
confirm
mechan
enhanc
pulmonari
diseas
follow
administr
inactiv
brsv
vaccin
remain
determin
one
studi
phenomenon
significantli
correl
high
concentr
brsvspecif
nonneutr
antibodi
decreas
level
product
interferon
circul
lymphocyt
addit
experi
examin
constitu
thorac
lymph
correl
diseas
sever
concentr
brsvspecif
immunoglobulin
e
base
result
hypothes
respiratori
diseas
associ
brsv
infect
immunopatholog
event
result
stimul
brvsspecif
thelper
lymphocyt
rel
import
put
mechan
versu
cytolyt
effect
viru
airway
parenchym
epithelium
remain
determin
role
brsv
infect
brsvspecif
immun
respons
propos
pathogenesi
atyp
interstiti
pneumonia
alp
feedlot
cattl
base
larg
similar
gross
histolog
lesion
brsvinfect
cattl
cattl
contrast
previou
recent
investig
fail
detect
activ
infect
brsv
case
alp
feedlot
cattl
examin
retrospect
howev
brsvimmun
statu
cattl
examin
support
primari
role
pneumotoxic
indol
pathogenesi
data
document
increas
plasma
concentr
latter
rumen
metabolit
feedlot
cattl
alp
compar
control
occur
absenc
appar
pulmonari
involv
brsv
signific
respiratori
pathogen
contrast
prospect
experi
demonstr
mild
subclin
brsv
infect
synerg
subleth
intox
indol
classic
prototyp
toxic
rumen
metabolit
enhanc
pulmonari
diseas
whether
synerg
involv
immunopathogen
compon
determin
role
brsv
alp
remain
unresolv
propos
recent
specif
antibodi
haemolytica
immun
complex
result
interact
bacteria
antibodi
lung
may
compon
pathogenesi
broc
retrospect
immunohistolog
examin
lung
tissu
case
natur
acquir
bovin
pneumon
mannheimeosi
immun
complex
observ
alveolar
space
wall
anim
studi
potenti
immunopatholog
effect
prospect
mice
immun
purifi
outer
membran
protein
omp
haemolytica
subsequ
challeng
intratrach
live
bacteria
omp
immun
mice
develop
high
serum
immunoglobulin
g
respons
omp
necrot
bronchointerstiti
pneumon
lesion
similar
find
case
brdc
immun
complex
complement
identifi
alveolar
wall
damag
pulmonari
tissu
base
find
propos
immun
complex
diseas
might
compon
pathogenesi
brdc
associ
mannheimia
infect
logic
immunolog
standpoint
base
natur
inflammatori
lesion
complement
fixat
could
mediat
neutrophil
infiltr
like
possibl
specif
antibodi
haemolytica
could
result
previou
natur
exposur
vaccin
could
present
mani
cattl
develop
pneumon
mannheimiosi
result
may
explain
previou
observ
administr
earli
crude
mannheimia
vaccin
associ
diseas
enhanc
cattl
subsequ
develop
mannheimiaassoci
brdc
find
support
concept
better
defin
subunit
mannheimia
vaccin
appar
contain
offend
bacteri
compon
associ
improv
efficaci
fewer
advers
reaction
sever
speci
mycoplasma
recogn
etiolog
agent
calf
pneumonia
increas
evid
mycoplasma
bovi
emerg
least
better
recogn
respiratori
pathogen
older
feedlot
cattl
north
america
elsewher
sever
factor
could
contribut
appar
emerg
better
control
bacteri
pathogen
use
vaccin
antibiot
interact
pathogen
bovin
viral
diarrhea
could
allow
bovi
better
assum
role
opportunist
pathogen
increas
virul
bovi
asyetunidentifi
host
manag
factor
studi
conduct
suggest
immun
respons
bovi
may
contributori
lesion
develop
base
larg
promin
immunoglobulin
lesser
extent
immunoglobulin
cell
peripheri
characterist
necrot
bovisassoci
lesion
propos
specif
immunoglobulin
rather
cellmedi
immun
respons
least
partli
respons
lesion
seen
calv
infect
bovi
although
specif
role
identifi
contrast
murin
mycoplasmosi
caus
pulmoni
pneumonia
colon
epithelium
small
airway
caus
hyperplasia
bronchusassoci
lymphoid
tissu
balt
bovi
invas
hyperplasia
balt
promin
featur
pulmonari
lesion
cattl
consist
lack
mitogen
activ
least
strain
bovi
cultur
bovin
lymphocyt
indic
lymphoid
involv
lesion
caus
nonspecif
mitogen
effect
term
brdc
impli
syndrom
result
complex
interact
host
pathogen
environment
factor
render
understand
probabl
multifactori
natur
diseasespar
immunolog
respons
difficult
tradit
identif
protect
immun
respons
approach
context
vaccin
trial
protect
diseas
spare
correl
variou
immun
respons
usual
context
experiment
infect
correl
reduct
natur
acquir
diseas
immun
respons
primarili
serolog
epidemiolog
also
less
perfect
approach
problem
recent
studi
continu
use
approach
better
understand
immun
respons
brdc
review
pathogenspecif
manner
base
seroconvers
viru
isol
bovin
coronaviru
bcv
becom
recogn
potenti
etiolog
agent
brdc
whether
pathogen
emerg
wake
improv
control
respiratori
viru
infect
simpli
better
recogn
diagnos
remain
determin
date
publish
prospect
studi
address
protect
immunolog
mechan
bcv
infect
respiratori
tract
data
indic
commerci
avail
vaccin
contain
either
modifi
live
inactiv
bcv
appli
prophylaxi
brdc
although
discuss
protect
immunolog
mechan
would
larg
specul
point
evid
similar
case
bcvassoci
enter
matern
antibodi
diseasespar
effect
bcvassoci
respiratori
diseas
young
calv
john
elli
dvm
phd
unpublish
data
seroconvers
associ
recent
reduc
risk
bcv
shed
feedlot
calv
given
genet
antigen
related
bcv
isol
caus
enter
respiratori
consist
quasispecif
natur
bcv
like
neonat
enter
infect
bcv
induc
mucos
system
antibodi
reduc
respiratori
diseas
result
subsequ
respiratori
bcv
previou
studi
provid
evid
cellmedi
antibodi
respons
associ
diseas
spare
bovin
herpesvirusi
bhvi
infectionsi
cellular
respons
compris
cytotox
mediat
lymphocyt
natur
killerlik
cell
secret
interferon
cytokin
cellular
cytokin
respons
viru
may
also
contribut
patholog
infect
cattl
protect
antibodi
recogn
major
surfac
glycoprotein
viru
function
virusneutr
cellmedi
cytotox
possibl
block
virusmedi
immunosuppress
effectsp
substanti
recent
advanc
relat
better
understand
specif
immunolog
mechan
involv
protect
bhviassoci
respiratori
diseas
durat
protect
respons
confer
infect
vaccin
recent
vaccin
trial
examin
new
vaccin
technolog
includ
vector
vaccin
continu
support
concept
cellmedi
immun
local
system
antibodi
respons
associ
protect
use
nonspecif
immun
stimul
time
experiment
bhvl
infect
day
infect
associ
diseas
spare
reduc
viral
shed
howev
immunolog
mechan
involv
examinedh
recent
seroepidemiolog
studi
provid
support
evid
bhvl
continu
import
pathogen
feedlot
cattl
system
antibodi
respons
associ
diseas
spare
lo
cattl
seroconvert
bhvl
giv
glycoprotein
feedlot
decreas
risk
undifferenti
fever
wherea
high
concentr
bhvl
specif
antibodi
arriv
possibl
suggest
previou
exposur
latent
infect
associ
increas
mortalitylo
recent
develop
challeng
model
result
clinic
diseas
lesion
similar
observ
natur
acquir
brsv
infect
allow
consider
progress
made
understand
protect
immun
brsvassoci
brdc
case
primari
brsv
infect
suscept
naiv
cattl
sever
line
evid
indic
local
cellmedi
immun
critic
protect
immunolog
mechan
anim
recov
infect
previous
hypothes
demonstr
genet
restrict
cellmedi
cytotox
cell
pulmonari
lavag
fluid
phenotyp
analys
use
monoclon
antibodi
indic
lymphocyt
primari
cell
mediat
diseasespar
respons
respons
cell
shown
occur
absenc
signific
local
system
antibodi
respons
case
cattl
prime
immunolog
respond
brsv
vaccin
modifi
live
vaccin
probabl
natur
acquir
infect
exposur
antibodi
cellmedi
respons
associ
diseas
spare
viral
clearanc
clinic
protect
coincid
simultan
appear
mucos
antibodi
immunoglobulin
immunoglobulin
g
cytotox
cell
lung
primari
anamnest
serum
antibodi
respons
viru
interestingli
parenter
vaccin
prime
anamnest
mucos
antibodi
respons
vaccineassoci
secret
interferon
peripher
blood
leukocyt
assumedli
cell
correl
protect
vaccin
calv
detect
lung
along
cytokin
naiv
cattl
antigen
specif
antibodi
respons
associ
protect
determin
result
studi
continu
support
conceptb
neutral
antibodi
respons
epitop
fusion
f
protein
viru
protect
respons
epitop
f
protein
may
differ
vaccin
infect
cattl
shown
recent
respons
specif
epitop
f
g
protein
infect
cattl
may
relat
bovin
leukocyt
antigen
bola
may
relat
differ
diseas
sever
among
brsvinfect
cattl
contrast
previou
recent
studi
also
document
signific
diseas
spare
reduct
durat
magnitud
shed
brsv
engend
commerci
avail
adjuv
inactiv
protect
highli
correl
high
concentr
nonneutr
antibodi
prime
interferon
respons
time
challeng
whether
correl
nonneutr
antibodi
protect
indic
causal
relationship
remain
determin
readili
appar
nonneutr
antibodi
prevent
viral
replic
mediat
viral
clearanc
moreov
support
previou
concern
nonneutr
antibodi
demonstr
recent
passiv
protect
brsvinfect
calv
mediat
f
proteinspecif
neutral
fusioninhibit
monoclon
antibodi
nonneutr
monoclon
antibodi
whether
viru
signific
respiratori
pathogen
continu
matter
debat
despit
ubiquit
presenc
cattl
popul
identif
lung
cattl
die
pneumonia
fact
experiment
condit
least
isol
viru
produc
clinic
diseas
pulmonari
lesionsi
recent
investig
shed
littl
addit
light
natur
protect
immun
pi
v
infect
cattl
one
recent
studi
demonstr
signific
diseasespar
effect
intranas
administ
temperaturesensit
pi
v
vaccin
small
number
calv
use
challeng
model
produc
sever
clinic
diseas
lung
lesion
signific
correl
reduc
pulmonari
patholog
serum
antibodi
time
challeng
specif
protect
immunolog
mechan
identifi
relat
paramyxovirus
biolog
brsv
pi
v
similar
howev
evid
includ
result
recent
studi
pin
infect
bronchoalveolar
macrophag
like
immunosuppress
effect
bovin
immun
system
recent
document
case
nevertheless
given
biolog
similar
like
immun
respons
similar
recent
identifi
brsv
challeng
studi
like
import
confer
protect
pi
v
infect
howev
date
detail
immunolog
studi
yet
conduct
context
experiment
phv
challeng
model
result
signific
clinic
diseas
pulmonari
lesion
recent
accomplish
brsv
whether
bovin
viral
diarrhea
viru
bvdv
pneumotrop
viru
henc
true
respiratori
pathogen
somewhat
debat
although
direct
infect
cell
respiratori
system
ie
epitheli
cell
airway
pulmonari
parenchyma
document
uncommonli
bvdv
infect
cattl
bvdv
gener
thought
respiratori
pathogen
cattl
data
recent
studi
virul
type
ii
bvdv
isol
gross
histolog
lesion
pneumonia
commonli
found
experiment
infect
cattl
compat
idea
least
isol
bvdv
quasispeci
respiratori
pathogen
cattl
often
immunohistochem
evid
bvdv
antigen
found
bronchoalveolar
macrophag
pulmonari
microvasculatur
lymphoid
tissu
find
togeth
common
isol
bacteria
case
recent
evid
associ
bvdv
respiratori
arthrit
mycoplasma
bovi
infect
support
concept
bvdv
act
respiratori
pathogen
primarili
context
local
system
immunosuppress
virtu
infect
mononuclear
phagocyt
includ
bronchoalveolar
macrophag
sever
studi
publish
unpublish
form
inhous
studi
conduct
biolog
compani
substanti
vaccin
contain
modifi
live
bvdv
type
confer
signific
protect
develop
clinic
diseas
lesion
subsequ
infect
emerg
virul
bvdv
type
ii
data
experiment
infect
support
retrospect
epidemiolog
studi
document
diseasespar
effect
vaccin
protect
cattl
respiratori
clinic
manifest
infect
emerg
bvdv
type
ii
strain
avail
data
suggest
current
avail
vaccin
protect
cattl
pneumotrop
bvdv
type
strain
well
possibl
newer
vaccin
contain
type
bvdv
engend
improv
protect
immun
acut
bvdv
compar
monotyp
vaccin
test
direct
compar
experi
protect
immunolog
mechan
confer
vaccin
specif
identifi
like
involv
anamnest
system
antibodi
respons
perhap
local
immun
respons
stimul
system
replic
vaccin
viru
antibodi
respons
like
involv
lymphocyt
helper
howev
date
littl
direct
evid
role
cellmedi
immun
confer
protect
bvdv
infect
diseas
correl
higher
arriv
bvdvspecif
antibodi
decreas
risk
undifferenti
fever
feedlot
cattl
recent
epidemiolog
evid
support
role
system
antibodi
protect
bvdvassoci
diseas
lo
role
virul
factor
haemolytica
includ
lkt
lipopolysaccharid
pathogenesi
brdc
well
establish
review
veterinari
clinic
north
america
food
anim
practic
evid
experiment
epidemiolog
studi
document
relationship
protect
high
concentr
passiv
matern
activ
deriv
antibodi
specif
virul
factor
primarili
lkt
variou
omp
bacteria
recent
studi
continu
identifi
specif
antigen
inclus
improv
vaccin
includ
transferrinbind
protein
avail
data
continu
support
concept
optim
immunogen
protect
cattl
haemolyticaassoci
respiratori
diseas
contain
lkt
variou
pasteurella
multocida
gener
consid
less
pathogen
respiratori
tract
haemolytica
necessit
organ
initi
primari
infect
may
attribut
number
efficaci
virul
factor
may
explain
associ
subacut
chronic
bronchopneumonia
rather
acut
fibrin
pneumonia
immunogen
stimul
protect
immun
antibodi
respons
p
multocida
less
well
studi
haemolytica
thought
compris
similar
array
omp
includ
ironregul
recent
studi
vaccin
design
prevent
hemorrhag
septicemia
system
form
p
multocida
infect
cattl
caus
asian
strain
bacteria
identifi
transferrinbind
protein
new
vaccin
candid
similar
haemolytica
hemophilu
somnu
recogn
primari
caus
bronchopneumonia
cattl
gener
thought
subacut
chronic
associ
haemolytica
appar
geograph
distribut
preval
report
pulmonari
cardiac
diseas
feedlot
cattl
associ
pathogen
north
america
increas
recogn
preval
northern
latitud
canada
reason
known
could
relat
differ
manag
practic
includ
antibiot
usag
asyetunidentifi
differ
geograph
distribut
strain
h
somnu
simpli
recognit
infect
diseas
caus
bacterium
difficult
isol
laboratori
nevertheless
organ
possess
complement
virul
factor
includ
lipooligosaccharid
similar
properti
haemolytica
lipopolysaccharid
omp
includ
ironbind
protein
fe
receptorlik
protein
contribut
virul
surviv
organ
previou
studi
document
least
partial
efficaci
h
somnu
vaccin
identifi
omp
includ
ironbind
protein
immunogen
stimul
protect
antibodi
respons
haemolytica
p
multocida
antibodi
respons
liposaccharid
thought
diseasespar
effect
recent
publish
studi
knowledg
area
specif
immun
respons
engend
protect
h
somnusassoci
brdc
although
continu
work
biolog
immunolog
mycoid
infect
caus
contagi
pleuropneumonia
cattl
agent
current
exot
north
america
contrast
recent
studi
concern
immunolog
bovi
infect
may
emerg
pathogen
feedlot
cattl
current
vaccin
contain
bovi
commerci
avail
north
america
studi
complet
publish
unit
kingdom
document
efficaci
combin
vaccin
contain
bovi
reduc
respiratori
diseas
associ
bovi
infect
alon
togeth
detail
immunolog
studi
indic
protect
bovi
infect
depend
kill
pathogen
antibodymedi
cellular
purifi
bovisspecif
immunoglobulin
ig
promot
kill
macrophag
wherea
promot
kill
neutrophil
bovisspecif
igm
ineffect
promot
cellular
cytotox
either
phagocyt
incub
bovi
specif
igm
alon
effect
viabil
organ
experiment
infect
calv
igacontain
cell
lymphocyt
plasma
cell
present
submucosa
tissu
nasal
caviti
trachea
bovisspecif
iga
present
tracheobronchi
wash
sera
igacontain
cell
howev
promin
infiltr
cell
lesion
role
immunoglobulin
isotyp
kill
bovi
document
recent
publish
studi
examin
mechan
protect
pathogenesi
bovi
infect
cattl
howev
recent
studi
focus
better
definit
potenti
molecular
vaccin
candid
antigen
specif
bovin
immun
respons
bovi
role
protect
pathogenesi
current
poorli
understood
